NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
NORTHWEST BIOTHERAPEUTICS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.16−0.00 (-0.88%)
Close on Oct 19, 2026
- Market cap
- $254.79M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Northwest Biotherapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2026 | Jul 31, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 17, 2026 | Jul 20, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Apr 15, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 24, 2025 | Apr 7, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 15, 2026 | Jan 15, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 29, 2025 | Jan 2, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 29, 2025 | Nov 28, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2025 | Nov 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 27, 2025 | Oct 31, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 24, 2025 | Oct 30, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 23, 2025 | Oct 24, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 9, 2025 | Oct 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 15, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 31, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 19, 2024 | Dec 26, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 31, 2024 | Nov 1, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 9, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 2, 2024 | Aug 2, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 29, 2024 | Jul 3, 2024 | SEC EDGAR |
| Current report | 8-K | May 31, 2024 | Jun 4, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 29, 2024 | Jun 3, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 10, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 26, 2024 | May 2, 2024 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2023 | Apr 29, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 18, 2024 | Mar 22, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 8, 2024 | Mar 14, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 5, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2023 | Nov 16, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 9, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2023 | Aug 9, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2023 | May 10, 2023 | SEC EDGAR |
| Current report | 8-K | Mar 2, 2023 | Mar 8, 2023 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2022 | Feb 28, 2023 | SEC EDGAR |
| Current report | 8-K | Jan 9, 2023 | Jan 13, 2023 | SEC EDGAR |
| Current report | 8-K | Dec 30, 2022 | Jan 6, 2023 | SEC EDGAR |